Join the Upcoming Webinar on Precision Medicine for Neurological Diseases

A free webinar titled “The Evolution of Precision Medicine in Age-Related Neurological Diseases” is set to take place on November 7, 2025, at 11:00 AM EST (5:00 PM CET). This event, hosted by Xtalks, will delve into how precision medicine strategies focused on biomarkers and targeted therapeutics are advancing the treatment of neurological diseases affecting older adults.

Older adults often face significant challenges in clinical research, primarily due to the complexity of neurological diseases, biological variability, and trial designs that overlook their needs. This webinar aims to address these issues by exploring how precision medicine can enhance treatment outcomes through the sub-classification of conditions and tailored trial strategies.

The speakers will include leading experts from the clinical research sector of Thermo Fisher Scientific. Presenters such as Panos Papanastasopoulos, Associate Medical Director, and Debra Schaumberg, ScD, OD, MPH, Global Head of Strategic Scientific Solutions for Ophthalmology, will share insights on patient-centric trial designs. They will discuss how these designs can bridge the gap between scientific research and real-world impact for older adults living with neurological diseases.

A central focus of the session will be on the importance of biomarkers in redefining patient populations. Recent advancements in biomarker science are paving the way for more precise clinical trials, particularly in areas like cognitive decline, movement disorders, and neuro-ophthalmology. The speakers will elaborate on how these biomarkers facilitate the identification of disease-specific populations, making clinical trials more effective in evaluating therapies, including innovative options like cell and gene therapies.

The webinar will also highlight the unique challenges that older adults encounter in clinical trial participation. Factors such as mobility limitations and comorbidities often hinder their involvement. Therefore, the discussion will emphasize the need for trial designs that simplify protocols and adjust safety assessments, making them more accommodating for elderly participants.

By integrating patient needs with scientific rigor, precision medicine holds the potential to close efficacy gaps and deliver meaningful therapies to populations frequently underrepresented in research. Attendees will gain valuable perspectives on how these advancements can lead to improved health outcomes for older adults.

Professionals interested in this timely topic can register for the webinar by visiting the Xtalks website. This event promises to provide essential insights into how patient-centric approaches enhance precision medicine for age-related neurological diseases.

Xtalks, powered by Honeycomb Worldwide Inc., is recognized for its role as a leading provider of educational webinars in the life sciences and healthcare sectors. Each year, thousands of industry practitioners rely on Xtalks for access to quality content and updates on industry developments, regulations, and job opportunities.

For additional information about the webinar or to register, please visit the Xtalks website.